UK markets open in 6 hours 33 minutes
NIKKEI 225
37,722.53 -239.27 (-0.63%) HANG SENG
16,251.84 +2.87 (+0.02%) CRUDE OIL
82.76 +0.07 (+0.08%) GOLD FUTURES
2,382.30 -6.10 (-0.26%) DOW
37,753.31 -45.66 (-0.12%) Bitcoin GBP
48,983.99 -2,228.21 (-4.35%)
Geron Corporation (GERN)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 3.5800 |
| Open | 3.6300 |
| Bid | 3.6800 x 300 |
| Ask | 3.7100 x 5600 |
| Day's range | 3.6300 - 3.8000 |
| 52-week range | 1.6400 - 4.0500 |
| Volume | |
| Avg. volume | 12,518,667 |
| Market cap | 2.164B |
| Beta (5Y monthly) | 0.61 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.3200 |
| Earnings date | 09 May 2024 - 13 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 5.08 |
Simply Wall St.Geron Corporation (NASDAQ:GERN) Is Expected To Breakeven In The Near Future
We feel now is a pretty good time to analyse Geron Corporation's ( NASDAQ:GERN ) business as it appears the company may...
Business WireGeron to Participate at Upcoming Investor Conferences in April
FOSTER CITY, Calif., April 03, 2024--Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced that John A. Scarlett, M.D., Geron’s Chairman and Chief Executive Officer, is scheduled to present at the following virtual investor conferences:
ZacksBiotech Stock Roundup: GERN, CRNX Gain on Updates, BMY's CAR T Cell Therapy News & More
Geron Corporation (GERN) and Crinetics Pharmaceuticals (CRNX) gain on positive regulatory and study updates.
© 2024 Yahoo. All rights reserved.